Assoc. Prof. Nargiz Majidova

Assoc. Prof. Nargiz Majidova
Academic Title :
Assoc. Prof.

Assoc. Prof. Dr. Nargiz Majidova is a Medical Oncology specialist at Medical Park Maltepe.

Education and Academic Qualifications

  • Faculty of Medicine, Ondokuz Mayıs University, Samsun (2009–2015)
  • Internal Medicine Residency, Ondokuz Mayıs University, Samsun (2016–2020)
  • Medical Oncology Fellowship, Marmara University, Istanbul (2021–2024)

Areas of Interest

  • Breast cancer
  • Lung cancer
  • Colorectal cancers
  • Gastric (stomach) cancer
  • Pancreatic cancer
  • Prostate cancer
  • Kidney cancer
  • Gynecological cancers
  • Internal Medicine Specialist, Ondokuz Mayıs University, Samsun (2016–2020)
  • Internal Medicine Specialist, VM Medical Park Samsun Hospital (2020–2021)
  • Medical Oncology Specialist, Marmara University, Istanbul (2021–2024)
  • Medical Oncology Specialist, Maltepe Medical Park Hospital (2024–2026)
  • Medical Oncologist, Medical Park Istanbul Oncology Hospital (2026–present)
  • Turkish Society of Medical Oncology
  • European Society for Medical Oncology (ESMO)
  • American Society of Clinical Oncology (ASCO)
  • Turkish Medical Association
  • Majidova N, Demirağ G, Pehlivanlar Küçük M. Rare widespread skin metastasis in lung cancer. Tuberk Toraks. 2018;66(3):249–52.
  • Majidova N, et al. Gustave Roussy Immune Score (GRIm-Score) Predicts Prognosis in Non-Small Cell Lung Cancer Patients Undergoing Nivolumab: A Multicenter Retrospective Study from Turkiye. International Journal of Hematology and Oncology. 2024;34(4):206–12.
  • Majidova N, Simsek F, Biter S, Yaslikaya S, et al. Prognostic Factors Associated with Resected Osteosarcoma: Efficacy of Adjuvant Setting, Real-World Experience. UHOD – International Hematology-Oncology Journal. 2024;34(1):20–7.
  • Majidova N, Seyyar M, Güren AK, Kocaaslan E, Kırcalı MF, et al. Lung Immune Prognostic Index (LIPI): Prognostic predictor for patients with extensive-stage small-cell lung cancer. Marmara Medical Journal. 2025;38(1):24–8.
  • Majidova N, Sarı M, Kahvecioglu FA, Ozcan E, et al. Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma.
Share :